Skip to main content
. 2016 Apr 25;10:636. doi: 10.3332/ecancer.2016.636

Figure 4. Diffuse immunoreactivity of squamous cell carcinoma and the overlying epithelium for cytokeratin AE1/AE3 and focal/weak immunoreactivity of the sarcomatoid component (Immunoperoxidase with haematoxylin counterstain, X100).

Figure 4.